Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Makes it tough to watch insiders sell shares so low
View:
Post by mdjbrown on May 25, 2023 10:31pm

Makes it tough to watch insiders sell shares so low

Filed 2023-05-24 14:34
 
Tx date 2023-05-19
$LABS
MediPharm Labs Corp.
Pidduck, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-142,181.34
-2,031,162 vol
$0.07 each
6,175,735
Comment by Solid1 on May 26, 2023 8:57am
I don't think he's selling them to an unknown person.... 
Comment by mdjbrown on May 26, 2023 12:17pm
Tough to tell S1 May 19 daily volume was huge in comparison to months previous and it looks like the Omega platform accomodated transactions in the amount of 1.178 million shares that day but the shares were sold on the open market. Just not a great look when there is so much uncertainty https://www.stockwatch.com/Quote/Detail?C:LABS&snapshot=SX
Comment by subaru1 on May 26, 2023 4:24pm
2023-05-19 Pidduck, David -2,031,162 Sell in the public market at $0.07 per share -$142,181.34 6,175,735 2023-05-19 Pidduck, David 3,275,863 Exercise of rights at $0.07 per share $232,586.27 8,206,897 2023-05-19 Pidduck, David -3,275,863 ...more  
Comment by alleyesonme on May 26, 2023 8:12pm
Share based compensation is how a small Corp like labs can have a high calibre pharmaceutical CEO...sold these shares the same day it was awarded and still adds 1.2 million shares to his huge pile...nothing to be concerned about...the way this was done was very professional...this millionaire just needs to be paid...and he's doing a great job.
Comment by subaru1i on May 26, 2023 9:06pm
MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA
Comment by subaru1i on May 26, 2023 12:53pm
You can look it at negatively but you can also incorporate wealth planning, no different than estate planning when you transfer an asset from a parent to a child while the parent is still living...a form of wealth planning/preservation.    The transfer of assets merely being accomodated by a stock exchange platform.   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities